Glaxo halts vaccine trial in pregnant women
An independent committee have recommended GlaxoSmithKline pause a trial of its vaccine candidate against the respiratory syncytial virus (RSV), reports The Times. The trial involved the creation of a vaccine to protect newborn children against RSV, which is a cause of pneumonia in toddlers and the elderly. It was designed to be given to pregnant … Read more